Summary: S.1803 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for S.1803. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (09/13/2017)

Marijuana Effective Drug Studies Act of 2017 or the MEDS Act

This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.

Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.